Orders from 190 AUD Free delivery from 395 AUD Ready for pickup dead drop: collect in 5 min

Substances · Cathinone derivatives

2-CMC

C10H12ClNO CAS 1246911-70-5 Analytical reference material — not for human consumption
2-CMC, educational illustration of the molecular structure
Educational illustration of the molecular structure. This is not a photograph of the product.
Preferred name
2-CMC
IUPAC name
1-(2-chlorophenyl)-2-(methylamino)propan-1-one
Parent CAS number (reference)
1246911-70-5
Molecular formula
C10H12ClNO
Molecular weight
197.66 g/mol
InChIKey
UHVGPEBZWPKWNT-UHFFFAOYSA-N
PubChem
CID 112693018
Source
PubChem
Verified synonyms & catalog abbreviations
2-Chloromethcathinone 2CMC 2 CMC 2-Chloro-N-methylcathinone

Matching Listings in This Store's Catalog

Verified Neurochemical & Toxicological Intelligence

2-CMC (2-Chloromethcathinone)

Stimulant (Selective NDRA — Norepinephrine-Dopamine Releasing Agent) Substituted cathinone (ortho-chlorinated methcathinone)
Verified PubChem & CAS Identity C10H12ClNO · CAS 692720-34-6 · CID 112693018
Calibrated Physical Form Pure Crystalline / Analytical Powder (≥98%)
≥98% Analytical Purity Verified 197.66 g/mol
Peer-Reviewed & Agency Citations 3 · verified sources

Receptor Telemetry & Mechanism of Action

DAT Dopamine Transporter 179 nM
NET Norepinephrine Transporter 93 nM

Steric hindrance from the ortho-chlorine atom dramatically alters transporter recognition compared to 3-CMC and 4-CMC. In rat brain synaptosomes (Walther et al., 2018), 2-CMC acts as a selective norepinephrine and dopamine releasing agent (NET EC50 = 93 ± 6 nM; DAT EC50 = 179 ± 22 nM) with nearly 20-fold weaker serotonin release than 4-CMC (SERT EC50 = 2,815 ± 620 nM; SERT/DAT ratio ~15.7). Consequently, 2-CMC produces catecholaminergic stimulation devoid of a heavy serotonergic 'roll'.

Biotransformation & Active Metabolites

2-Chlorocathinone (ortho-chlorocathinone) and dihydro-2-CMC are expected analytical metabolites based on methcathinone pathways; reference-standard suppliers note that specific human metabolic and toxicological studies have not yet been published.

Temporal Pharmacokinetics

Mild, clear-headed, functional psychostimulant profile predicted from its NDRA pharmacology—offering wakefulness, conversational alertness, and modest dopaminergic mood lift without serotonergic haziness.

  1. Onset 20–45 minutes oral (tentative class estimate; 5–15 minutes mucosal)
  2. Peak Window 45–90 minutes
  3. Total Window 2.5–4.5 hours oral (tentative class estimate; 1.5–2.5 hours mucosal)
  4. Residual / Half-Life 2–6 hours of residual adrenergic wakefulness; human elimination half-life and clinical toxicokinetics are unverified.

No independent human quantitative brackets trials or TripSit/PsychonautWiki tables exist for 2-CMC. Because 2-CMC is ~6.9-fold weaker at DAT than 3-CMC and largely inactive at SERT, users expecting a 4-MMC/4-CMC empathogenic surge face a major trap: escalating past ~150–180 mg cannot unlock serotonergic mood elevation because NET potency (EC50 = 93 nM) outpaces DAT (179 nM), driving disproportionate tachycardia, hypertension, and peripheral vasoconstriction instead.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
25–40 mg (tentative SAR estimate)
Cognitive & Sensory

Subtle mental clearing, reduced drowsiness, and slight increase in task attentiveness.

Somatic & Autonomic

Minimal somatic sensation; faint uptick in resting pulse.

Light
40–75 mg (tentative SAR estimate)
Cognitive & Sensory

Crisp wakefulness, calm focus, light sociability, and mild mood elevation without perceptual distortion.

Somatic & Autonomic

Mild appetite suppression, dry mouth, and gentle adrenergic energy.

Common Reference
75–130 mg (tentative SAR estimate)
Cognitive & Sensory

Clear dopaminergic motivation, talkativeness, enhanced alertness, and social confidence with minimal empathogenic softness.

Somatic & Autonomic

Noticeable heart-rate and blood-pressure elevation, sweating, mild jaw tension, and cool fingertips.

Strong
130–180 mg (tentative SAR estimate)
Cognitive & Sensory

Restless, jittery stimulation, racing thoughts, hyper-vigilance, and rising adrenergic tension.

Somatic & Autonomic

Pronounced tachycardia (NET-driven), vasoconstriction, bruxism, tremor, and post-peak insomnia.

Heavy / Toxic Zone
180–250+ mg (tentative SAR estimate)
Cognitive & Sensory

Acute anxiety, panic, irritability, working-memory disruption, and potential paranoid overstimulation.

Somatic & Autonomic

Severe hypertension, chest tightness, palpitations, peripheral vasospasm, hyperthermia, and seizure risk.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

MAOIs (phenelzine, tranylcypromine, moclobemide, harmala alkaloids)

Potent norepinephrine and dopamine release (NET EC50 = 93 nM) under MAO inhibition triggers life-threatening hypertensive crisis, cerebral hemorrhage, and hyperthermia.

Other strong stimulants and vasoconstrictors (Cocaine, alpha-PVP, alpha-PHP, MDPHP, Hexen, 25x-NBOMe)

Synergistic noradrenergic vasoconstriction and cardiac workload risk acute arrhythmias, vasospasm, and myocardial ischemia.

Tramadol

Lowers seizure threshold while compounding noradrenergic hypertension and convulsion risk.

Elevated Hazard — Avoid

MDMA, 4-MMC, or 4-CMC

Adds heavy noradrenergic cardiovascular and thermoregulatory strain onto serotonergic entactogens.

Alcohol and GHB/GBL

Masks subjective sedation, leading to excessive depressant intake and cardiovascular/dehydration strain.

Caution / Receptor Attenuation

High-dose Caffeine or Nicotine

Amplifies 2-CMC's prominent NET-mediated heart-rate elevation, jitteriness, and peripheral coldness.

SSRIs and SNRIs

SNRIs can additively increase noradrenergic blood-pressure and heart-rate elevation.

Structural Isomer & Sibling Comparison

Within the CMC triad, 2-CMC is by far the least potent and most catecholamine-selective isomer: it is ~6.9-fold less potent at DAT than 3-CMC (179 nM vs. 26 nM) and ~19.5-fold weaker at SERT than 4-CMC (2,815 nM vs. 144 nM). Pharmacologically, 2-CMC parallels ortho-methylated 2-MMC—acting as a clearer, non-empathogenic stimulant, though ~2.2-fold less potent at DAT than 2-MMC (81 nM).

Physicochemical Stability & Storage

Form: White to off-white crystalline solid or clear crystal shards as the monohydrochloride salt (recrystallized HCl mp 172–174 °C; lit. 159–161 °C). · Soluble in PBS (pH 7.2, ~5 mg/mL), ethanol (~5 mg/mL), DMF (~5 mg/mL), and DMSO (~10 mg/mL).

Subject to beta-keto reduction and instability in biological/aqueous media; store sealed, dry, and protected from light at cool temperatures.

Cross-Tolerance & Dependence Profile

Expected cross-tolerance with all dopaminergic/noradrenergic stimulants (2-MMC, 3-CMC, amphetamine), halving in ~3–7 days and returning to baseline in 1–2 weeks. Psychological repeated exposure cravings occur if chased for mood elevation, while long-term human toxicity remains unstudied.

Comprehensive Analytical & Toxicological Monograph

2-CMC (2-chloromethcathinone; 1-(2-chlorophenyl)-2-(methylamino)propan-1-one; freebase CAS 692720-34-6 [also cataloged under 1246911-70-5], hydrochloride CAS 90869-66-2, PubChem CID 112693018) is the ortho-chlorinated regioisomer of the chloromethcathinone series, supplied in both active stock and weekly queue slot #2 as pure analytical crystalline powder or crystals (C10H12ClNO, 197.66 g/mol). Because ortho-substitution introduces steric bulk adjacent to the beta-carbonyl group, 2-CMC displays a sharply distinct pharmacological profile from 3-CMC and 4-CMC: in rat brain synaptosome assays (Walther et al., 2018), it functions as a selective norepinephrine-dopamine releasing agent (NET EC50 = 93 nM, DAT EC50 = 179 nM) while largely sparing the serotonin transporter (SERT EC50 = 2,815 nM). Forensic reference producers note that human physiological and toxicological studies have not yet been published for 2-CMC; tentative harm-reduction brackets inferred from synaptosomal potency and ortho-methyl sibling 2-MMC place oral threshold activity around 25–40 mg, light functional alertness at 40–75 mg, common clear-headed stimulation at 75–130 mg, strong adrenergic intensity at 130–180 mg, and heavy cardiovascular overstimulation above 180–250 mg across an estimated 2.5–4.5 hour oral arc. Crucially, because NET release outpaces DAT release and SERT activity is minimal, escalating amounts in search of a 4-CMC- or 4-MMC-like serotonergic 'roll' will only trigger rapid heart rate, hypertension, and peripheral vasoconstriction rather than empathogenic warmth. Compared to 3-CMC and 4-CMC, 2-CMC is gentler and non-empathogenic, closely echoing 2-MMC at roughly half its DAT potency. Never combine 2-CMC with MAOIs, tramadol, cocaine, pyrovalerones, MDMA/4-MMC, or 25x-NBOMe compounds.

Chemical Architecture & Structural Profile

2-CMC (1-(2-chlorophenyl)-2-(methylamino)propan-1-one) is a reference compound belonging to the Cathinone derivatives class, characterized by the molecular formula C10H12ClNO and a molar mass of 197.66 g/mol. The parent molecule is indexed under CAS registry number 1246911-70-5 and in the NCBI PubChem database as CID 112693018 (Standard InChIKey: UHVGPEBZWPKWNT-UHFFFAOYSA-N). This molecule shares its empirical formula (C10H12ClNO) with positional or structural isomers; unambiguous analytical identification requires matching the full IUPAC structure, CAS number (1246911-70-5), and spectroscopic profile.

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 2-CMC is indexed within the Cathinone derivatives structural group. As a substituted beta-ketone (cathinone derivative), this compound requires strict analytical verification and has documented contraindications with MAOIs, serotonergic agents, and other stimulants. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations